R-3750 in Patients With Mild to Moderate Ulcerative Colitis

NCT05666960 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

36

Enrollment

INDUSTRY

Sponsor class

Conditions

Ulcerative Colitis Chronic Mild
Ulcerative Colitis Chronic Moderate
Ulcerative Colitis Chronic
Ulcerative Colitis

Interventions

DRUG: R-3750

Sponsor

Rise Therapeutics LLC

Collaborators

[object Object]
[object Object]